160 related articles for article (PubMed ID: 2949770)
21. Clinicopathological study of canine transmissible venereal tumour in leishmaniotic dogs.
Marino G; Gaglio G; Zanghì A
J Small Anim Pract; 2012 Jun; 53(6):323-7. PubMed ID: 22489831
[TBL] [Abstract][Full Text] [Related]
22. Sequential changes in peripheral blood leukocyte adherence inhibition (LAI) reactivity during progressive growth and spontaneous regression of canine transmissible venereal sarcoma.
Harding MW; Yang TJ
Int J Cancer; 1981 Sep; 28(3):361-6. PubMed ID: 7319678
[TBL] [Abstract][Full Text] [Related]
23. Immunotherapy for the treatment of canine transmissible venereal tumor based in dendritic cells pulsed with tumoral exosomes.
Ramos-Zayas Y; Franco-Molina MA; Hernádez-Granados AJ; Zárate-Triviño DG; Coronado-Cerda EE; Mendoza-Gamboa E; Zapata-Benavides P; Ramírez-Romero R; Santana-Krymskaya SE; Tamez-Guerra R; Rodríguez-Padilla C
Immunopharmacol Immunotoxicol; 2019 Feb; 41(1):48-54. PubMed ID: 30334465
[No Abstract] [Full Text] [Related]
24. Lack of beta 2-microglobulin on the surface of canine transmissible venereal tumor cells.
Cohen D; Shalev A; Krup M
J Natl Cancer Inst; 1984 Feb; 72(2):395-401. PubMed ID: 6363791
[TBL] [Abstract][Full Text] [Related]
25. Canine transmissible venereal tumour: a review.
Ganguly B; Das U; Das AK
Vet Comp Oncol; 2016 Mar; 14(1):1-12. PubMed ID: 23981098
[TBL] [Abstract][Full Text] [Related]
26. Transmission of canine transmissible venereal tumour between two dogs in the UK.
Hayes AM; Schiavo L; Constantino-Casas F; Desmas I; Dobson J; Draper A; Elliot J; Genain MA; Wang J; Murchison EP
J Small Anim Pract; 2023 Sep; 64(9):590-594. PubMed ID: 36990106
[TBL] [Abstract][Full Text] [Related]
27. [Growth and regression course of canine transmissible sarcoma transplanted into beagles and mongrel dogs (author's transl)].
Kudo T; Koike T; Otomo K; Sakai T
Nihon Juigaku Zasshi; 1981 Jun; 43(3):421-8. PubMed ID: 7321366
[No Abstract] [Full Text] [Related]
28. Autologous canine immunotherapy: short-time generated dendritic cells loaded with canine transmissible venereal tumor-whole lysate.
Franco-Molina MA; Ramos-Zayas Y; Coronado-Cerda EE; Mendoza-Gamboa E; Zapata-Benavides P; Santana-Krymskaya SE; Tamez-Guerra R; Rodríguez-Padilla C
Immunopharmacol Immunotoxicol; 2018 Oct; 40(5):437-443. PubMed ID: 30507311
[TBL] [Abstract][Full Text] [Related]
29. Effects of immunotherapy of IL-6 and IL-15 plasmids on transmissible venereal tumor in beagles.
Chou PC; Chuang TF; Jan TR; Gion HC; Huang YC; Lei HJ; Chen WY; Chu RM
Vet Immunol Immunopathol; 2009 Jul; 130(1-2):25-34. PubMed ID: 19200609
[TBL] [Abstract][Full Text] [Related]
30. Canine transmissible venereal tumor (TVT): a review.
Vermooten MI
J S Afr Vet Assoc; 1987 Sep; 58(3):147-50. PubMed ID: 3334057
[TBL] [Abstract][Full Text] [Related]
31. Does the tumour microenvironment alter tumorigenesis and clinical response in transmissible venereal tumour in dogs?
Ballestero Fêo H; Montoya Flórez L; Yamatogi RS; Prado Duzanski A; Araújo JP; Oliveira RA; Rocha NS
Vet Comp Oncol; 2018 Sep; 16(3):370-378. PubMed ID: 29508538
[TBL] [Abstract][Full Text] [Related]
32. Stromal cells and extracellular matrix components in spontaneous canine transmissible venereal tumour at different stages of growth.
Mukaratirwa S; Chimonyo M; Obwolo M; Gruys E; Nederbragt H
Histol Histopathol; 2004 Oct; 19(4):1117-23. PubMed ID: 15375754
[TBL] [Abstract][Full Text] [Related]
33. Isolation of viable cells in canine transmissible sarcoma (CTS) using density gradient centrifugation.
Okamoto Y; Minami S; Matsuhashi A; Fujinaga T
J Vet Med Sci; 1996 Nov; 58(11):1149-51. PubMed ID: 8959669
[TBL] [Abstract][Full Text] [Related]
34. Cranial metastasis of canine transmissible venereal sarcoma.
Placke ME; Hill DL; Yang TJ
Zentralbl Veterinarmed A; 1987 Feb; 34(2):125-32. PubMed ID: 3109161
[No Abstract] [Full Text] [Related]
35. Measurement of the rate of death of canine transmissible venereal tumour cells transplanted into dogs and nude mice.
Holmes JM
Res Vet Sci; 1981 Mar; 30(2):248-50. PubMed ID: 7255917
[TBL] [Abstract][Full Text] [Related]
36. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
[TBL] [Abstract][Full Text] [Related]
37. Canine transmissible venereal tumour: a morphological and immunohistochemical study of 11 tumours in growth phase and during regression after chemotherapy.
Gonzalez CM; Griffey SM; Naydan DK; Flores E; Cepeda R; Cattaneo G; Madewell BR
J Comp Pathol; 2000 May; 122(4):241-8. PubMed ID: 10805977
[TBL] [Abstract][Full Text] [Related]
38. [Transmissible venereal sarcoma in a dog (Sticker's sarcoma) in Somalia].
Cristofori F; Aaden AS; Gheddi AM
Rev Elev Med Vet Pays Trop; 1985; 38(3):235-8. PubMed ID: 3841957
[No Abstract] [Full Text] [Related]
39. Mitosis and apoptosis in canine cutaneous histiocytoma and transmissible venereal tumour.
Guvenc T; Haligur M; Orman MN; Haziroglu R
Acta Vet Hung; 2002; 50(3):315-21. PubMed ID: 12237973
[TBL] [Abstract][Full Text] [Related]
40. Canine transmissible venereal tumor cell depletion of B lymphocytes: molecule(s) specifically toxic for B cells.
Liao KW; Hung SW; Hsiao YW; Bennett M; Chu RM
Vet Immunol Immunopathol; 2003 May; 92(3-4):149-62. PubMed ID: 12730015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
